Physician profile
James W Cheek
NPI 1962495168
$831.87
in general payments reported to CMS, 2019-2025
19 companies · $18.02 in 2025
The $18.02 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $66.54 · 2021: $179 · 2022: $246 · 2023: $86.34 · 2024: $54.51 · 2025: $18.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $119.27 | 2020-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $114.34 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $75.72 | 2021-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $64.98 | 2019-2025 | |
| Kaleo, INC. | $56.40 | 2019-2022 | |
| Sanofi Pasteur INC. | $55.49 | 2019-2023 | |
| Sobi, INC | $49.18 | 2019-2022 | |
| Corium, LLC | $44.09 | 2022-2024 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $40.85 | 2020-2023 | Crysvita |
| Neos Therapeutics, LP | $29.43 | 2022 | |
| Nestle Healthcare Nutrition INC. | $29.37 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $22.14 | 2024 | Koselugo |
| Tris Pharma INC | $21.37 | 2019 | |
| Genzyme Corporation | $20.78 | 2019 | |
| Glaxosmithkline, LLC. | $19.53 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $17.62 | 2019 | |
| Hologic Sales and Service, LLC | $17.62 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.61 | 2019 | |
| Masimo Corporation | $16.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cheek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.